Skip to main content

Table 2 The proportion of patients who were dispensed an opioid analgesic

From: Too much or too little opioids to patients receiving opioid agonist therapy in Norway (2013–2017): a prospective cohort study

Year

2013

2014

2015

2016

2017

Opioid analgesics

No. (%*)

No. (%*)

No. (%*)

No. (%*)

No. (%*)

Number of patients

7544

7763

7820

7690

7585

Strong opioid analgesics

 Oxycodone

234 (3)

226 (3)

205 (3)

231 (3)

246 (3)

 Morphine

184 (2)

143 (2)

120 (2)

134 (2)

149 (2)

 Fentanyl

79 (1)

58 (1)

39 (0)

11 (0)

34 (0)

 Buprenophine (non OAT)

129 (2)

138 (2)

154 (2)

163 (2)

145 (2)

 Ketobemidone

51 (1)

55 (1)

48 (1)

49 (1)

31 (0)

 Pethidine

6 (0)

6 (0)

5 (0)

<  5 (0)

5 (0)

 Hydromorphone

12 (0)

5 (0)

<  5 (0)

<  5 (0)

<  5 (0)

Weak opioid analgesics

 Codeine

822 (11)

799 (10)

781 (10)

730 (9)

690 (9)

 Tramadol

392 (5)

397 (5)

398 (5)

375 (5)

417 (5)

 Tapentadol

14 (0)

7 (0)

6 (0)

10 (0)

10 (0)

  1. The table displays the proportion of patients on OAT who were dispensed a weak and a strong opioid analgesics in the period 2013–2017. We only included opioid analgesics that had marketing authorization in Norway in the study period
  2. No.: Number of patients, OAT Opioid agonist therapy
  3. * Percent of patients who were dispensed an OAT opioid